{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=statins", "query": { "intervention": "statins" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 454, "total_pages": 46, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=statins&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T14:11:51.627Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01455935", "title": "Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Anti-platelets and statin", "type": "DRUG" }, { "name": "alteplase", "type": "DRUG" }, { "name": "intra arterial intervention", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Jacobs Neurological Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 90, "start_date": "2011-11", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2012-03-30", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01455935" }, { "nct_id": "NCT05984953", "title": "Rosuvastatin and Evolocumab for Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "statin", "type": "DRUG" }, { "name": "evolocumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 195, "start_date": "2013-08-01", "completion_date": "2022-10-28", "has_results": false, "last_update_posted_date": "2023-08-09", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05984953" }, { "nct_id": "NCT01218204", "title": "A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidaemias", "Dyslipidemias" ], "interventions": [ { "name": "10mg atorvastatin", "type": "DRUG" }, { "name": "80mg atorvastatin", "type": "DRUG" }, { "name": "GSK1292263 Placebo", "type": "DRUG" }, { "name": "100mg GSK1292263", "type": "DRUG" }, { "name": "300mg GSK1292263", "type": "DRUG" }, { "name": "800mg GSK1292263", "type": "DRUG" }, { "name": "10mg ezetimibe", "type": "DRUG" }, { "name": "Washout", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 287, "start_date": "2010-09-14", "completion_date": "2011-06-29", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 21, "location_summary": "Anniston, Alabama • Chula Vista, California • Stockton, California + 15 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01218204" }, { "nct_id": "NCT00797407", "title": "Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypercholesterolemia", "Aches", "Cramps", "Weakness" ], "interventions": [ { "name": "Creatine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2006-08", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2008-11-25", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 1, "location_summary": "Wooster, Ohio", "locations": [ { "city": "Wooster", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00797407" }, { "nct_id": "NCT02666664", "title": "Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia", "Atherosclerotic Cardiovascular Diseases" ], "interventions": [ { "name": "ETC-1002", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Esperion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2230, "start_date": "2016-01-21", "completion_date": "2018-03-28", "has_results": true, "last_update_posted_date": "2020-05-11", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 48, "location_summary": "Huntsville, Alabama • Cottonwood, Arizona • Phoenix, Arizona + 45 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Cottonwood", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02666664" }, { "nct_id": "NCT01263938", "title": "Modulation of Monocyte Activation by Atorvastatin in HIV Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Dementia" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2011-09", "completion_date": "2017-10", "has_results": true, "last_update_posted_date": "2019-05-01", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01263938" }, { "nct_id": "NCT04753606", "title": "Randomized Study of Obicetrapib as an Adjunct to Statin Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemias", "High Cholesterol", "Hypercholesterolemia" ], "interventions": [ { "name": "Obicetrapib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NewAmsterdam Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 120, "start_date": "2021-02-18", "completion_date": "2021-08-30", "has_results": true, "last_update_posted_date": "2024-07-12", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 19, "location_summary": "Anniston, Alabama • Huntington Park, California • Los Angeles, California + 15 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04753606" }, { "nct_id": "NCT01764633", "title": "Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "Evolocumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 27564, "start_date": "2013-02-08", "completion_date": "2016-11-11", "has_results": true, "last_update_posted_date": "2024-05-28", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 326, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 275 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01764633" }, { "nct_id": "NCT06455488", "title": "MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ventricular Tachycardia" ], "interventions": [ { "name": "Ventricular Tachycardia Ablation", "type": "PROCEDURE" }, { "name": "ICD Implant", "type": "DEVICE" }, { "name": "Antiarrhythmic drug", "type": "DRUG" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "Cardioversion", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "CorVita Science Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2020-07-20", "completion_date": "2030-07-20", "has_results": false, "last_update_posted_date": "2024-06-12", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06455488" }, { "nct_id": "NCT00249899", "title": "Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Lapaquistat acetate and stable statin therapy", "type": "DRUG" }, { "name": "Stable statin therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 649, "start_date": "2005-11", "completion_date": "2007-03", "has_results": false, "last_update_posted_date": "2012-05-24", "last_synced_at": "2026-09-10T14:11:51.627Z", "location_count": 13, "location_summary": "Santa Ana, California • Chicago, Illinois • Iowa City, Iowa + 10 more", "locations": [ { "city": "Santa Ana", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Auburn", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT00249899" } ] }